NCT00870363: A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy |
|
|
| Completed | 4 | 44 | US | maraviroc in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor), Selzentry, maraviroc plus raltegravir in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor), Selzentry (maraviroc), efavirenz [or other NNRTI (non-nucleoside reverse transcriptase inhibitor)], Sustiva | University of California, Davis | HIV Infections | 04/13 | 04/13 | | |
| Terminated | 4 | 4 | Europe | raltegravir and atazanavir and ritonavir, Isentress (raltegravir), Reyataz (atazanavir), Norvir (ritonavir), tenofovir/emtricitabine and atazanavir and ritonavir, tenofovir/emtricitabine (Truvada), atazanavir (Reyataz), ritonavir (norvir) | Giovanni Di Perri, University of Turin, Italy, University of Milan | HIV Infection, Osteopenia | 12/16 | 12/16 | | |
